Tag: stalled
Biogen’s lagging Vumerity, stalled by the pandemic, faces ‘critical’ stretch ahead,...
Biogen’s Tecfidera follow-up Vumerity hit the market late last year, but eight months into the launch, the new multiple sclerosis drug is yet to meaningfully take off.
The drug...